We previously identified TMCC2 as a protein that interacted differentially with normal versus Alzheimer's disease-risk forms of both apolipoprotein E (apoE) and the amyloid protein precursor (APP). The gene discussed is TMCC2; the disease is early-onset autosomal dominant Alzheimer disease.